Literature DB >> 10199908

Sequential MRI, SPECT and PET in respiratory syncytial virus encephalitis.

K Hirayama1, H Sakazaki, S Murakami, S Yonezawa, K Fujimoto, T Seto, K Tanaka, H Hattori, O Matsuoka, R Murata.   

Abstract

We report on a 3-year-old girl with respiratory syncytial virus (RSV) encephalitis manifested by disturbance of consciousness, conjugate eye deviation, anuria, truncal ataxia and intention tremor. T2-weighted magnetic resonance imaging (MRI) showed hyperintense areas in the cerebellar cortex. No lesion was detected in the cerebral cortex, pons or spinal cord. The hyperintense areas in the cerebellar cortex diminished with recovery from the clinical manifestations and had resolved 2 months after onset. The MRI lesions in the cerebellum were considered to be due to oedema. SPECT and positron emission tomography (PET), performed 3 months after onset, disclosed areas of hypoperfusion and hypometabolism at the same sites. One year after onset, MRI showed mild atrophy of the cerebellum. Hypoperfusion on SPECT and hypometabolism on PET remained. Neuroimaging showed that ataxia and tremor in this case were the result of cerebellitis. The patient has no neurological deficit except for mild truncal ataxia. This patient is a rare example of RSV encephalitis.

Entities:  

Mesh:

Year:  1999        PMID: 10199908     DOI: 10.1007/s002470050589

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  12 in total

1.  Impaired learning resulting from respiratory syncytial virus infection.

Authors:  Janyra A Espinoza; Karen Bohmwald; Pablo F Céspedes; Roberto S Gómez; Sebastián A Riquelme; Claudia M Cortés; Javier A Valenzuela; Rodrigo A Sandoval; Floria C Pancetti; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

2.  Atypical Presentations of Respiratory Syncytial Virus Infection: Case Series.

Authors:  Nawal Al-Maskari; Jalila Mohsin; Amal Al-Maani; Nabil Al-Macki; Suad Al-Ismaili
Journal:  Sultan Qaboos Univ Med J       Date:  2016-02-02

3.  Respiratory syncytial virus-related encephalitis: magnetic resonance imaging findings with diffusion-weighted study.

Authors:  Arim Park; Sang-il Suh; Gyu-Ri Son; Young Hen Lee; Hyung Suk Seo; Baik-Lin Eun; Nam-Joon Lee; Hae-Young Seol
Journal:  Neuroradiology       Date:  2013-12-13       Impact factor: 2.804

Review 4.  Acute cerebellitis.

Authors:  Yukio Sawaishi; Goro Takada
Journal:  Cerebellum       Date:  2002-07       Impact factor: 3.847

5.  Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration.

Authors:  K-D Choi; J S Kim; S-H Park; Y K Kim; S E Kim; P S Smitt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 6.  Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review.

Authors:  Michael Eisenhut
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier.

Authors:  Antônio Kleiton de Sousa; Diva de Aguiar Magalhães; Jayro Dos Santos Ferreira; André Luiz Dos Reis Barbosa
Journal:  Med Hypotheses       Date:  2020-08-26       Impact factor: 1.538

Review 8.  Neurologic Alterations Due to Respiratory Virus Infections.

Authors:  Karen Bohmwald; Nicolás M S Gálvez; Mariana Ríos; Alexis M Kalergis
Journal:  Front Cell Neurosci       Date:  2018-10-26       Impact factor: 5.505

9.  Isolated cerebellar hypermetabolism on FDG PET in a case of remitted primary breast lymphoma.

Authors:  Arun Kumar Reddy; Sampath Santhosh; Bhagwant Rai Mittal; Anish Bhattacharya; Suresh C Sharma
Journal:  Indian J Nucl Med       Date:  2014-01

10.  Systemic inflammatory response syndrome and prolonged hypoperfusion lesions in an infant with respiratory syncytial virus encephalopathy.

Authors:  Kenji Miyamoto; Masahide Fujisawa; Hajime Hozumi; Tatsuo Tsuboi; Shigeko Kuwashima; Jun-ichi Hirao; Kenichi Sugita; Osamu Arisaka
Journal:  J Infect Chemother       Date:  2013-01-26       Impact factor: 2.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.